Article Versions Notes

Stępnicki P, Wośko S, Bartyzel A, Zięba A, Bartuzi D, Szałaj K, Wróbel TM, Fornal E, Carlsson J, Kędzierska E, et al. Development and Characterization of Novel Selective, Non-Basic Dopamine D₂ Receptor Antagonists for the Treatment of Schizophrenia. Molecules. 2023; 28(10):4211. https://doi.org/10.3390/molecules28104211

Stępnicki, Piotr, Sylwia Wośko, Agata Bartyzel, Agata Zięba, Damian Bartuzi, Klaudia Szałaj, Tomasz M. Wróbel, Emilia Fornal, Jens Carlsson, Ewa Kędzierska, and et al. 2023. "Development and Characterization of Novel Selective, Non-Basic Dopamine D₂ Receptor Antagonists for the Treatment of Schizophrenia" Molecules 28, no. 10: 4211. https://doi.org/10.3390/molecules28104211

Stępnicki, P., Wośko, S., Bartyzel, A., Zięba, A., Bartuzi, D., Szałaj, K., Wróbel, T. M., Fornal, E., Carlsson, J., Kędzierska, E., Poleszak, E., Castro, M., & Kaczor, A. A. (2023). Development and Characterization of Novel Selective, Non-Basic Dopamine D₂ Receptor Antagonists for the Treatment of Schizophrenia. Molecules, 28(10), 4211. https://doi.org/10.3390/molecules28104211